﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Sat, 04 Apr 2026 06:27:23 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/March-2025/rss/3112</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/March-2025/rss/3112" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New therapeutic agents marketed in 2024: Part 1]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2024-part-1</link><description><![CDATA[  Mark S. Johnson, PharmD, BCPS  

   

 FDA approved 50 new (“novel”) drugs in 2024 that had not been approved or marketed in the United States. These new drugs are classified as new molecular ...]]></description><pubDate>Fri, 07 Feb 2025 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2024-part-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3044]]></dc:identifier></item></channel></rss>